{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:08:11Z","timestamp":1791295691292,"version":"4.1.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T00:00:00Z","timestamp":1537228800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008731","name":"Association Europ\u00e9enne contre les Leucodystrophies","doi-asserted-by":"publisher","award":["ELA2012-013C2"],"award-info":[{"award-number":["ELA2012-013C2"]}],"id":[{"id":"10.13039\/501100008731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"DOI":"10.3389\/fnmol.2018.00336","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T04:30:35Z","timestamp":1537245035000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Drug Screening Identifies Sigma-1-Receptor as a Target for the Therapy of VWM Leukodystrophy"],"prefix":"10.3389","volume":"11","author":[{"given":"Andrea","family":"Atzmon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melisa","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reut","family":"Sharet-Eshed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yocheved","family":"Gilad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanoch","family":"Senderowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orna","family":"Elroy-Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/brain\/awv008","article-title":"Dysfunction in endoplasmic reticulum-mitochondria crosstalk underlies SIGMAR1 loss of function mediated motor neuron degeneration.","volume":"138","author":"Bernard-Marissal","year":"2015","journal-title":"Brain"},{"key":"B2","year":"2016","journal-title":"Discovery Studio Modeling Environment Release 2017."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049015","article-title":"Purkinje cell maturation participates in the control of oligodendrocyte differentiation: role of sonic hedgehog and vitronectin.","volume":"7","author":"Bouslama-Oueghlani","year":"2012","journal-title":"PLoS One"},{"key":"B4","doi-asserted-by":"publisher","first-page":"C817","DOI":"10.1152\/ajpcell.00139.2004","article-title":"Calcium, ATP, and ROS: a mitochondrial love-hate triangle.","volume":"287","author":"Brookes","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046715","article-title":"Poor cerebral inflammatory response in eIF2B knock-in mice: implications for the aetiology of vanishing white matter disease.","volume":"7","author":"Cabilly","year":"2012","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"publisher","first-page":"14071","DOI":"10.1073\/pnas.182542899","article-title":"Small molecule modulation of Smoothened activity.","volume":"99","author":"Chen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.26109","article-title":"PPP1R15A-mediated dephosphorylation of eIF2alpha is unaffected by Sephin1 or Guanabenz.","volume":"6","author":"Crespillo-Casado","year":"2017","journal-title":"Elife"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot087361","article-title":"Measuring mitochondrial transmembrane potential by TMRE staining.","volume":"2016","author":"Crowley","year":"2016","journal-title":"Cold Spring Harb Protoc."},{"key":"B9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1212\/WNL.52.2.346","article-title":"Eliprodil stimulates CNS myelination: new prospects for multiple sclerosis?","volume":"52","author":"Demerens","year":"1999","journal-title":"Neurology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1172\/JCI83908","article-title":"Astrocytes are central in the pathomechanisms of vanishing white matter.","volume":"126","author":"Dooves","year":"2016","journal-title":"J. Clin. Invest."},{"key":"B11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/nan.12411","article-title":"Bergmann glia translocation: a new disease marker for vanishing white matter identifies therapeutic effects of Guanabenz treatment.","volume":"44","author":"Dooves","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.4103\/1673-5374.217329","article-title":"Mitochondrial malfunction in vanishing white matter disease: a disease of the cytosolic translation machinery.","volume":"12","author":"Elroy-Stein","year":"2017","journal-title":"Neural Regen. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/B978-0-12-410529-4.00086-3","article-title":"\u201cVanishing white matter disease,\u201d in","author":"Elroy-Stein","year":"2015","journal-title":"Rosenberg\u2019s Molecular and Genetic Basis of Neurological and Psychiatric Disease"},{"key":"B14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1042\/BST0340022","article-title":"The large spectrum of eIF2B-related diseases.","volume":"34","author":"Fogli","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"B15","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nrn1990","article-title":"Morphogen to mitogen: the multiple roles of hedgehog signalling in vertebrate neural development.","volume":"7","author":"Fuccillo","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"B16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0022-3565(24)38131-5","article-title":"Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line.","volume":"289","author":"Ganapathy","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/jnc.13142","article-title":"Proteomics-level analysis of myelin formation and regeneration in a mouse model for Vanishing White Matter disease.","volume":"134","author":"Gat-Viks","year":"2015","journal-title":"J. Neurochem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1093\/brain\/awq180","article-title":"A mouse model for eukaryotic translation initiation factor 2B-leucodystrophy reveals abnormal development of brain white matter.","volume":"133","author":"Geva","year":"2010","journal-title":"Brain"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-015-0108-0","article-title":"A reliable computational workflow for the selection of optimal screening libraries.","volume":"7","author":"Gilad","year":"2015","journal-title":"J Cheminform"},{"key":"B20","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival.","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115683","article-title":"Glycolytic switch in response to betulinic acid in non-cancer cells.","volume":"9","author":"Heiss","year":"2014","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.mito.2012.01.001","article-title":"Microscale oxygraphy reveals OXPHOS impairment in MRC mutant cells.","volume":"12","author":"Invernizzi","year":"2012","journal-title":"Mitochondrion"},{"key":"B23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00439-005-0024-x","article-title":"Heightened stress response in primary fibroblasts expressing mutant eIF2B genes from CACH\/VWM leukodystrophy patients.","volume":"118","author":"Kantor","year":"2005","journal-title":"Hum. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature16991","article-title":"Crystal structure of eukaryotic translation initiation factor 2B.","volume":"531","author":"Kashiwagi","year":"2016","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ejmech.2014.04.019","article-title":"Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(1H)-quinolinone scaffold as a potential analgesic.","volume":"79","author":"Lan","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/ng764","article-title":"Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter.","volume":"29","author":"Leegwater","year":"2001","journal-title":"Nat. Genet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/cns.12768","article-title":"Sigma-1 receptor agonist increases axon outgrowth of hippocampal neurons via voltage-gated calcium ions channels.","volume":"23","author":"Li","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/glia.22639","article-title":"Effects of dextromethorphan on glial cell function: proliferation, maturation, and protection from cytotoxic molecules.","volume":"62","author":"Lisak","year":"2014","journal-title":"Glia"},{"key":"B29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1158\/1541-7786.MCR-15-0278","article-title":"Sonic hedgehog signaling drives mitochondrial fragmentation by suppressing mitofusins in cerebellar granule neuron precursors and medulloblastoma.","volume":"14","author":"Malhotra","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026992","article-title":"A point mutation in translation initiation factor eIF2B leads to function\u2013and time-specific changes in brain gene expression.","volume":"6","author":"Marom","year":"2011","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pharmthera.2009.07.001","article-title":"The pharmacology of sigma-1 receptors.","volume":"124","author":"Maurice","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076941","article-title":"Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival.","volume":"8","author":"Mori","year":"2013","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1089\/adt.2009.0198","article-title":"Discovery of chemical modulators of a conserved translational control pathway by parallel screening in yeast.","volume":"7","author":"Motlekar","year":"2009","journal-title":"Assay Drug Dev. Technol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/978-3-319-50174-1_10","article-title":"Sigma-1 receptors and neurodegenerative diseases: towards a hypothesis of sigma-1 receptors as amplifiers of neurodegeneration and neuroprotection.","volume":"964","author":"Nguyen","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.steroids.2015.02.003","article-title":"Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7beta-hydroxycholesterol-, or 24(S)-hydroxycholesterol: protective effects of alpha-tocopherol and docosahexaenoic acid (DHA; C22:6 n-3).","volume":"99","author":"Nury","year":"2015","journal-title":"Steroids"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1491","article-title":"Regulation of translation initiation factor eIF2B at the hub of the integrated stress response.","author":"Pavitt","year":"2018","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"B37","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/jnc.14024","article-title":"Mutant eIF2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease.","volume":"141","author":"Raini","year":"2017","journal-title":"J. Neurochem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jphs.2014.11.011","article-title":"The involvement of the sigma-1 receptor in neurodegeneration and neurorestoration.","volume":"127","author":"Ruscher","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.nbd.2016.10.006","article-title":"The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease.","volume":"97","author":"Ryskamp","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1007\/s00213-015-3997-8","article-title":"Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses.","volume":"232","author":"Sahlholm","year":"2015","journal-title":"Psychopharmacology (Berl.)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nature14957","article-title":"Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination.","volume":"526","author":"Samanta","year":"2015","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ymgme.2005.10.019","article-title":"Childhood ataxia with CNS hypomyelination\/vanishing white matter disease\u2013a common leukodystrophy caused by abnormal control of protein synthesis.","volume":"88","author":"Schiffmann","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00498","article-title":"Pharmacological brake-release of mRNA translation enhances cognitive memory.","volume":"2","author":"Sidrauski","year":"2013","journal-title":"Elife"},{"key":"B44","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.tips.2016.01.003","article-title":"The sigma-1 receptor as a pluripotent modulator in living systems.","volume":"37","author":"Su","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/35023008","article-title":"Effects of oncogenic mutations in smoothened and patched can be reversed by cyclopamine.","volume":"406","author":"Taipale","year":"2000","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.1201396","article-title":"Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis.","volume":"332","author":"Tsaytler","year":"2011","journal-title":"Science"},{"key":"B47","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/jnr.490210216","article-title":"Regional expression of myelin protein genes in the developing mouse brain: in situ hybridization studies.","volume":"21","author":"Verity","year":"1988","journal-title":"J. Neurosci. Res."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.32733","article-title":"The small molecule ISRIB rescues the stability and activity of Vanishing White Matter Disease eIF2B mutant complexes.","volume":"7","author":"Wong","year":"2018","journal-title":"Elife"},{"key":"B49","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.bbrc.2009.04.145","article-title":"Sonic hedgehog mediates BDNF-induced neuroprotection against mitochondrial inhibitor 3-nitropropionic acid.","volume":"385","author":"Wu","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/jcc.10306","article-title":"Detailed analysis of grid-based molecular docking: a case study of CDOCKER-A CHARMm-based MD docking algorithm.","volume":"24","author":"Wu","year":"2003","journal-title":"J. Comput. Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.yfrne.2010.12.001","article-title":"11beta-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress.","volume":"32","author":"Wyrwoll","year":"2011","journal-title":"Front. Neuroendocrinol."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0250-7","article-title":"Involvement of sigma-1 receptor in astrocyte activation induced by methamphetamine via up-regulation of its own expression.","volume":"12","author":"Zhang","year":"2015","journal-title":"J. Neuroinflamm."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1126\/science.aar5129","article-title":"Binding of ISRIB reveals a regulatory site in the nucleotide exchange factor eIF2B.","volume":"359","author":"Zyryanova","year":"2018","journal-title":"Science"}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2018.00336\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T17:47:56Z","timestamp":1751910476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2018.00336\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,18]]},"references-count":53,"alternative-id":["10.3389\/fnmol.2018.00336"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2018.00336","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,18]]},"article-number":"336"}}